No effect of CYP3A4 intron 6 C > T polymorphism (CYP3A4∗22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemia

2015-03-01

Additional Metadata
Keywords	Atorvastatin, Cholesterol, CYP3A4∗22, CYP3A5, Hypercholesterolemia, LDL cholesterol, Pharmacogenomics, Simvastatin
Persistent URL	doi.org/10.1515/dmdi-2014-0021, hdl.handle.net/1765/81034
Journal	Drug Metabolism and Personalized Therapy
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ragia, G., Kolovou, G., Tavridou, A., Elens, L., Tselepis, C., Elisaf, M., … Manolopoulos, V. (2015). No effect of CYP3A4 intron 6 C > T polymorphism (CYP3A4∗22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemia. Drug Metabolism and Personalized Therapy, 30(1), 43–48. doi:10.1515/dmdi-2014-0021

Publication